Skip to main content
Lumos Pharma, Inc. (LUMO)
Dec 12, 2024 - LUMO was delisted (reason: acquired by Double Point Ventures)
4.340
0.00 (0.00%)
Inactive · Last trade price on Dec 11, 2024

Lumos Pharma Revenue

Lumos Pharma had revenue of $726.00K in the quarter ending September 30, 2024, with 10,271.43% growth. This brings the company's revenue in the last twelve months to $2.21M, up 26.94% year-over-year. In the year 2023, Lumos Pharma had annual revenue of $2.05M with 34.67% growth.

Revenue (ttm)
$2.21M
Revenue Growth
+26.94%
P/S Ratio
16.06
Revenue / Employee
$66,818
Employees
33
Market Cap
37.54M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.05M528.00K34.67%
Dec 31, 20221.52M1.29M562.17%
Dec 31, 2021230.00K62.00K36.90%
Dec 31, 2020168.00K--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

LUMO News

More News